Digital therapeutics company HealthBeacon has agreed a multi-year commercial deal with one of the largest independent pharmacy benefits manager and specialty pharmacy services in the US, for inclusion in its patient service offering.
The Dublin headquartered firm develops products for managing injectable medications for people in the home.
It said the new deal makes its Injection Care Management System more widely available to the roughly nine million patients in the US that self-administer injections at home.
HealthBeacon expects to deploy up to 15,000 units of its Smart Sharps Bin, a US FDA cleared product which tracks and has been clinically proven to materially enhance patient adherence with medication schedules this year.
The company has a near-term target of 100,000 patients using its ICMS, representing an approximately ten-fold increase on the numbers units deployed by HealthBeacon at the end of 2021.
Jim Joyce, CEO and co-founder of HealthBeacon, said the signing of this contract is a significant milestone for HealthBeacon.
He said it will unlock greater access to its injection care management system for the millions of patients in the US that self-administer subcutaneous injections at home.
"It is also an important validation of HealthBeacon's technology and the clinical effectiveness of our product," Mr Joyce said.
"Moreover, it is an endorsement of our mission to become the world's leading digital therapeutics platform for injectable medications," he said.
"At HealthBeacon, our fundamental aim is to make our product globally accessible and this yet another landmark development as we work toward what we expect will be a ten-fold increase in the number of patients using our injection care management system by the end of next year," he added.
